Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-15
1994-10-04
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31485
Patent
active
053526805
ABSTRACT:
A motion provided to alleviate the tolerance to, or dependence on, an opiate analgesic, by the administration of an effective amount of a selective delta opioid receptor antagonist to a human patient in need of such treatment.
REFERENCES:
patent: 4440932 (1984-04-01), Kotick et al.
patent: 4761429 (1988-08-01), Blum et al.
patent: 4816586 (1989-03-01), Portoghese
patent: 4882335 (1989-11-01), Sinclair
patent: 5086058 (1992-02-01), Sinclair
J. S. Shaw et al., Life Sci., 31, 1259 (1982).
R. Cotton et al., Eur. J. Pharmacol., 97, 331 (1984).
P. S. Portoghese et al., J. Med. Chem., 31, 281 (1988).
P. S. Portoghese et al., J. Med. Chem., 33, 1547 (1990).
P. S. Portoghese et al., Eur. J. Pharmacol., 146, 185 (1988).
E. E. Abdelhamid et al., J. Pharmacol. Exp. Ther., 258, 299 (1991).
M. Gates et al., J. Med. Chem., 7, 127 (1964).
P. S. Portoghese et al., J. Med. Chem., 34, 1292 (1991).
T. J. Haley et al., Brit. J. Pharmacol., 12, 12 (1957).
E. L. Way et al., J. Pharmacol. Exp. Ther., 167 1 (1969).
I. Yano et al., Res. Commun. Chem. Pathol. Pharmacol., 16, 721 (1977).
G. Hayashi et al., Eur. J. Pharmacol., 16, 63 (1971).
P. S. Portoghese et al., J. Med. Chem., 23 233 (1980).
A. E. Takemori et al., Eur. J. Pharmacol., 70, 445 (1981).
S. J. Ward et al., J. Pharmacol. Ther., 220, 494 (1982).
G. E. DeLander et al., J. Pharmacol. Exp. Ther., 231, 91 (1984).
Q. Jiang et al., J. Pharmacol. Exp. Ther., 257, 1069 (1991).
M. Sofuoglu et al., J. Pharmacol. Exp. Ther., 257, 676 (1991).
P. S. Portoghese et al., J. Med. Chem., 33, 1714 (1990).
A. E. Takemori et al., J. Pharmacol. Exp. Ther., 246, 255 (1988).
A. E. Takemori et al., J. Pharmacol. Exp. Ther., 243, 91 (1987).
J. C. Froehlich et al., Alcoholism, Clin. Exp. Res., 15, 315, Abstract 20 (Apr. 1991).
J. C. Froehlich et al., Pharmacol. Biochem. Behavior, 35, 385 (1990).
J. C. Froelich et al, Psychopharmacol., 103, 467 (1991).
M. S. Yamamura et al., Life Sci., 50, PL119 (1992).
H. P. Rang, Brit. J. Pharmacol., 22, 356 (1964).
J. R. Volpicelli et al., Opioids, Bulimia and Alcohol: Abuse and Alcoholism, L. D. Reid, ed., Springer-Verlag, Pub. (1990) at pp. 195-214.
L. L. Werling et al., J. Pharmacol. Exp. Ther., 233, 722 (1985).
J. J. Gormley et al., Life Sci., 31, 1263 (1982).
J. S. Shaw et al., Life Sci., 31, 1259 (1982).
W. R. Martin, Pharmacol. Rev., 35, 283 (1984).
Portoghese Philip S.
Takemori Akira E.
Cintins Marianne M.
Jarvis William R. A.
Regents of the University of Minnesota
Woessner Warren D.
LandOfFree
Delta opioid receptor antagonists to block opioid agonist tolera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delta opioid receptor antagonists to block opioid agonist tolera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delta opioid receptor antagonists to block opioid agonist tolera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581460